Prevalence and clinical risk factors for methotrexate intolerance in patients with juvenile idiopathic arthritis
MTX intolerance is relatively common in pediatric patients with JIA and is associated with older age at disease onset and MTX initiation, as well as the use of MTX as first-line therapy.
Authors
- Dragana Lazarević (ORCID: https://orcid.org/0000-0001-8200-2859)
- Predrag Ostojić (ORCID: https://orcid.org/0000-0002-4035-9515)
- Maja Bijelic
- Gordana Sušić (ORCID: https://orcid.org/0000-0002-4991-831X)
- Goran Radunović (ORCID: https://orcid.org/0000-0002-4449-8969)
- Dušica Novaković (ORCID: https://orcid.org/0000-0003-1744-0101)
- Tijana Dimkić-Tomić
- Nataša Mujović
- Andjela Dimkic-Milenkovic
- Stefan Antonije Djordjevic
- Smiljka Kovacevic
- Hristina Petrovic
- Vladimir Milenkovic
Institutions
- University of Nis (RS)
- Uniwersytecki Szpital Dziecięcy (PL)
- Institute of Rheumatology (CZ)
- Center for Health, Exercise and Sport Sciences (RS)
- Centar za Promociju Nauke (RS)
- Children's Clinical University Hospital (LV)
- Klinika za psihijatriju Vrapče (HR)
Publication Details
- Journal
- ARP Rheumatology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.63032/wyvm2561
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00